Charles Morgan Kendrick JR insider trades: Elevance Health (ELV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | ELV | ↓ Sell | 3,196 | $284.92 | $911K | Direct | Mar 9, 2026 (3d) |
| Mar 5, 2025 | ELV | ↓ Sell | 3,504 | $396.30 | $1.4M | Direct | Mar 5, 2025 (0d) |
| Oct 18, 2024 | ELV | ↓ Sell | 7,417 | $432.14 | $3.2M | Direct | Oct 18, 2024 (0d) |
| Mar 8, 2024 | ELV | ↓ Sell | 2,432 | $500.46 | $1.2M | Direct | Mar 12, 2024 (4d) |
| Mar 9, 2023 | ELV | ↓ Sell | 2,314 | $462.22 | $1.1M | Direct | Mar 13, 2023 (4d) |
| Jun 9, 2022 | ANTM | ↓ Sell | 6,328 | $488.60 | $3.1M | Direct | Jun 13, 2022 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELV insiders
Open-market trades in the last 12 months
About Charles Morgan Kendrick JR's insider trades
Charles Morgan Kendrick JR is EVP & President, Commercial at Elevance Health (ELV). Since Jun 9, 2022, Charles has reported no open-market purchases and 6 sales worth $10.9M on SEC Form 4. In the last 12 months: 1 sale ($911K).
Their filings also include shares withheld for taxes (8 filings), grants and awards (7 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.